19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
The holiday season is nearly upon us, and the shopping frenzy is about to commence. This annual phen...
Read More >
After much consultation and heated debate, Vietnam adopted a new Labor Code on 20 November 2019 ("La...
Read More >
In Salazar v. McDonald’s Corp., the plaintiff argued that McDonald’s, a franchisor of fast food re...
Read More >
The “Setting Every Community Up for Retirement Enhancement Act (“the SECURE Act”) changes the tax...
Read More >
Entro il 1° gennaio 2020, tutte le imprese aventi più di 11 dipendenti in Francia devono aver eletto...
Read More >
Wage and hour laws. Child labor laws. OSHA laws. Immigration laws. When employers do not comply ...
Read More >